Bioassay-guided fractionation of the stem bark of Symphonia globulifera has yielded three known xanthones, ugaxanthone (1), mbarraxanthone (2) and gentisein (3), two biflavonoid derivatives named GB2 (4) and manniflavanone GB3 (5), and one new polyoxygenated xanthone with an isoprenoid group, named globulixanthone F (6). The structures of these compounds were elucidated by means of spectroscopic methods. The spectral data of 1 and 2 are reported here for the first time, as well as the antimicrobial activity of globulixanthone F against a range of microorganisms. We also report the total synthesis of the xanthone skeleton.
Air dried and ground stem bark of S. globulifera was extracted at room temperature with a mixture of CH 2 Cl 2 -MeOH (1:1). This extract was concentrated to dryness under vacuum and its antimicrobial activity against a range of micro-organisms was evaluated in vitro. Since it was active against strains of Gram-positive bacteria, namely Staphylococcus aureus, Bacillus subtilis, Vibrio anguillarium (MIC: 100 µg/mL for each organism) and Gram-negative bacteria Escherichia coli (MIC at 150 µg/mL), this extract was repeatedly subjected to silica gel column chromatographic purification to give a novel prenylated polyoxygenated xanthone, designated globulixanthone F 6, along with two known biflavonoids [biflavonoid GB2 (4) and maniflavanone GB3 (5)] and three known xanthone derivatives [ugaxanthone (1) , mbarraxanthone (2) and gentisein (3) ].
Although ugaxanthone (1) and mbarraxanthone (2) were mentioned by Locksley et al. in 1966 [4] , as an inseparable mixture, these two compounds were obtained during our study as pure products and we report their physical and spectral data for the first time (see experimental part and Table 1 ). Gentisein (3) was reported as a constituent of Gentiana species [5] , but this is the first time it has been isolated from the genus Symphonia. Beside gentisein, compounds 4 [6] and 5 [7] , previously isolated from Garcinia species, were obtained in large amounts; these two compounds showed interesting activities, as presented in Table 1 . The large amount of these two compounds, in addition to their antimicrobial activities may justify the use of Symphonia extracts in traditional medicine for the treatment of some infectious diseases. The AMB spin system corresponding to a 1,2,3-trisubsituted benzene ring could only be assigned to the H-2, H-3 and H-4 protons of a 1-hydroxyl xanthone ring A. This was further confirmed by the presence in the HMBC spectrum of 6 (figure 1) of a cross peak between the chelated hydroxyl group at δ 13.30 and C-2 (δ110.3), the triplet of the ABM spin system at δ 7.63 and C-1 (162.6), C-2 (110.3) and C-4 (106.4). It remained at this stage to establish unambiguously the position of the two free hydroxyl groups, the methoxyl and of course the 3,3-dimethylallyl moiety. Position 8, assigned to the 3,3-dimethylally moiety can only be explained by the deshielding (usual value δ 3.3-3.5) observed with the allyl protons of this group at δ 4.08 due to the anisotropic effect of the carbonyl group. This was confirmed by the HMBC spectrum (Figure 1 ), which showed a cross peak between the allylic protons at δ 4.08 and C-8 (δ 111.0), C-8a (δ 127.6) and a carbon bearing an oxygen at δ 144.1(C-7). Therefore, it remained to establish clearly the positions of each of the three oxygenated groups. Since the 13 C NMR chemical shift of the methoxyl group in the spectrum is diagnostic of its position on the aromatic ring [12, 13] , the value of δ 60.8 indicated that in compound 6 the methoxyl group could occupy either C-5 or C-6. The C-6 position assigned to the methoxyl group was established from the HMBC spectrum, which showed a long range cross peak between the free hydroxyl proton at δ 8.90 and C-5a (δ 145.8), C-5 (δ 144.2), C-6 (δ 144.8), C-7 (δ 144.1) and C-8 (δ 111.0) on the one hand, and on the other, a cross peak between the methoxyl group and the carbon at δ 144.8. These HMBC correlations showed clearly that one of the two free hydroxyls is borne by C-5 and the other by C-7. This was further confirmed by the NOESY spectrum (figure 1), which showed a cross peak between the free hydroxyl group proton and the methoxyl protons. Therefore, the structure of globulixanthone F (6) was assigned as 1,5,7-trihydroxy-6-methoxy-8-(3,3-dimethylallyl) xanthone.
Compounds 4, 5 and 6 were tested in an in vitro agar disc diffusion assay for their antimicrobial potential against representative Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria (Table 1 ). The activities of the three compounds were greater or equivalent to those demonstrated by streptomycin sulfate. Against the Gram-negative bacterium, Escherichia coli, while streptomycin sulfate was inactive, compounds 4 and 5 showed great activity (MIC 7.5 and 4.5 µg/mL respectively) as shown in Table 1 . 
Synthesis of xanthone derivatives:
A mixture of phloroglucinol and 5-methoxysalicilic acid was heated in the presence of P 2 O 5 / CH 3 SO 3 H during 15 hours to yield isogentisin (7). Isogentisin (7) was subjected, in the presence of K 2 CO 3 /acetone, to etherification with 3-chloro-3-methyl butyn to give compound 8 (scheme).
As compound 8 showed a triple bond, it was partially hydrogenated in the presence of palladium to give the ether 9. Compound 9 was further heated under reflux in the presence of N,N-dimethylanilin to give, after Claisen rearrangement, two C-γ,γ-dimethylalylated compounds 10 and 11. Mbarraxanthone (2) was finally obtained by demethylation of compound 11, which was heated in the presence of borobromide in methylene chloride [14] .
Experimental
General procedures: All melting points were determined on a Buchi apparatus and are uncorrected. IR spectra in KBr were recorded on a Perkin-Elmer B4FT-IR spectrometer, and UV in MeOH on a Kronton-Uvikon 932 spectrometer. EIMS were obtained on a Nermag Sidar V3.0 and with LKS 9000 S mass spectrometers, and the HRMS with a V.G. analytical ZAB-H mass spectrometer.
1 H (300.13 MHz) and 13 C (75.45 MHz) NMR spectra were performed on an AC 300 Bruker instrument, with TMS as internal standard.
1 H assignment was made using 2D COSY and NOESY (mixing time 800 ms) experiments, while 13 C assignment was made using 2D HSQC and HMBC experiments. Silica gel, 230-400 mesh (Merck) and silica gel, 70-230 mesh (Merck), were used for flash and column chromatography, respectively, while precoated aluminum sheets of silica gel 60 F 254 (Merck) were used for TLC with a mixture of n-hexane-ethyl acetate as eluent; compounds were visualized by UV (254 nm) and CeSO 4 -H 2 SO 4 .
Plant material: Stem bark of Symphonia globulifera
Linn. f was collected in March 2001, at Yaoundé, Cameroon, and identified at the National Herbarium, Yaoundé, Cameroon, where voucher (2235/SRFK) samples are deposited.
Extraction and isolation:
Air dried powdered stem bark of S. globulifera (8 kg) was extracted twice during 48 h at room temperature with CH 2 Cl 2 /MeOH (1:1) (12 L). Removal of the solvent under reduced pressure yielded a dark brown oily solid (180 g). This was evaluated in vitro for antimicrobial activity and potency against Gram-positive (Staphylococcus aureus, Bacillus subtilis, Vibrio anguillarium) and Gram-negative (Escherichia coli) bacteria. MIC values of the CH 2 Cl 2 /MeOH extract, when assayed against Gram-positive and Gram-negative bacteria were 100 μg/mL and 150 μg/mL, respectively. The crude extract (180 g) was separated into three main fractions by flash chromatography eluting, respectively, with n-hexane-ethyl acetate (3:1); (1:1) and (1:3). These fractions were purified as follows:
Fraction 1, eluted with n-hexane-ethyl acetate (3:1), was concentrated to dryness to give a viscous residue (15 g ). Repeated silica gel column chromatography of this residue, eluting with n-hexane and n-hexane-ethyl acetate mixtures of increasing polarity, afforded, in addition to globulixanthone F (6) (70 mg) and pure compound 3 (0.5 g), a mixture of compounds 1 and 2. This mixture was further separated by preparative TLC over silica gel, eluted with n-hexane-ethyl acetate (4:1), to give ugaxanthone (1) (40 mg) and mbarraxanthone (2) (7): To a solution of 5-methoxysalicilic acid (9 g, 53.5 mmol) and phloroglucinol (7 g, 55 mmol) was added ZnCl 2 (22.44 g) and POCl 3 (20 mL). The mixture was heated at 65-70°C for 3 h. The resulting mixture was quenched with ice and extracted with CH 2 Cl 2 . Column chromatography (n-hexane/EtOAc 9:1) afforded 7 (7.76 g , 60%).
Synthesis of isogentisein
MP: 238-242°C (lit.: 239-240°C) [5] . IR (KBr): 3440, 3242, 1658, 1572, 1482 Compound 11 (0.70 mmol) was subjected to demethylation [14] in the presence of borobromide in methylene chloride to yield mbarraxanthone (2) (0.62 mmol) Antimicrobial assay: The extracts and isolated compounds from S. globulifera were tested against Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633), Vibrio anguillarium (19264) and Escherichia coli (ATCC 8739). The qualitative antimicrobial assay employed was a classic disc diffusion procedure using Mueller Hinton Agar (DIFCO) [15] . Paper discs were impregnated with 20 μL of DMSO solution of each sample at 1 mg/mL (20 µg/disc) and allowed to evaporate at room temperature. Streptomycin sulfate (S. aureus, B. subtilis, V. anguillarium) and gentamicin (E. coli) at 20 µg/disc were used as standard positive controls. The plates with micro-organisms were incubated at 30°C for 18 h when the diameter of the inhibition zones around each disc were measured and recorded. As the sensitivity of the disc bioassay is very low, final activity was determined using a minimum inhibitory concentration (MIC) method. The MIC values were determined by the standard broth microdilution method in Mueller-Hinton, with inoculums of 10 4 CFU/mL. To insure that the density of diluted cultures was within the range, several dilution plate counts were made for each culture. Tubes were inoculated with micro-organisms at room temperature. The MIC values were determined after 24 h of incubation. Streptomycin sulfate and gentamicin were also used as positive controls in the assay system for Gram-positive and Gram-negative bacteria, respectively.
